Management of Incomplete RBBB with 1mm ST-Elevation in V1-V2
This ECG pattern requires immediate differentiation between Brugada syndrome and acute coronary syndrome (ACS), with the clinical context being absolutely critical—if the patient has chest pain or ischemic symptoms, treat as NSTE-ACS and proceed to urgent coronary angiography; if asymptomatic or found incidentally, consider Brugada syndrome and avoid treating as STEMI. 1
Critical Decision Point: Clinical Context
The presence of incomplete RBBB with ST-elevation in V1-V2 creates diagnostic ambiguity that must be resolved by clinical presentation:
If Patient Has Chest Pain or Ischemic Symptoms:
Treat as Non-ST-Elevation ACS (NSTE-ACS), NOT as STEMI, because:
- Incomplete RBBB does not prevent interpretation of ST-segments (unlike complete LBBB) 2
- 1mm ST-elevation in V1-V2 with RBBB pattern does not meet STEMI criteria, which require ≥0.2 mV (2mm) in men >40 years or ≥0.25 mV in men <40 years in V2-V3 2
- This presentation falls into the "no persistent ST-segment elevation" category 1
Immediate Management Algorithm:
Obtain serial troponins (at presentation and 6-12 hours later) 3, 1
- High-sensitivity troponin preferred
- If elevated → confirms NSTEMI
Initiate NSTE-ACS medical therapy immediately 1, 4:
- Aspirin 150-300 mg loading dose
- P2Y12 inhibitor: Clopidogrel 600 mg (or ticagrelor/prasugrel if not going to CABG within 5 days)
- Anticoagulation: LMWH (enoxaparin) or unfractionated heparin
- Beta-blocker (if no contraindications)
- High-dose statin (atorvastatin 80 mg or rosuvastatin 40 mg)
- Nitrates if ongoing chest pain
Risk stratify for timing of angiography 4:
- Immediate (<2 hours) if: hemodynamic instability, ongoing refractory chest pain, life-threatening arrhythmias, heart failure
- Early (within 24 hours) if: elevated troponin (NSTEMI), dynamic ST-T changes, GRACE score >140
- Selective invasive strategy if low risk after negative troponins
If Patient is Asymptomatic (Incidental Finding):
Consider Brugada syndrome, which classically presents as:
- RBBB pattern with ST-elevation in V1-V3 5, 6, 7
- Structurally normal heart
- Risk of sudden cardiac death from polymorphic VT/VF 5, 8
Diagnostic Workup:
- Obtain previous ECGs for comparison—is this new or chronic?
- Detailed history: syncope, family history of sudden death, arrhythmias
- Echocardiogram to exclude structural heart disease 6
- Consider provocative testing with IV ajmaline, flecainide, or procainamide to unmask type 1 Brugada pattern 8
- Genetic testing if Brugada suspected (SCN5A mutations) 9
Common Pitfalls to Avoid
Do NOT give thrombolytics based on this ECG pattern alone—1mm ST-elevation in V1-V2 with incomplete RBBB does not meet STEMI criteria 2
Do NOT dismiss as "just RBBB" if patient has chest pain—incomplete RBBB allows ST-segment interpretation and this could represent ACS 2, 10
Do NOT confuse with STEMI criteria—the threshold for ST-elevation in V2-V3 is 2mm in men >40 years, not 1mm 2
Beware of Brugada mimics in symptomatic patients—always check troponins and consider angiography if clinical suspicion for ACS is high 6, 8
Key Distinguishing Features
| Feature | NSTE-ACS | Brugada Syndrome |
|---|---|---|
| Symptoms | Chest pain, dyspnea | Usually asymptomatic or syncope |
| Troponin | Elevated | Normal |
| ST-elevation | Transient, dynamic | Persistent, may be intermittent |
| Response to beta-agonists | No effect | Normalizes ECG [8] |
| Structural heart disease | Often present | Absent [5,6] |
The bottom line: Clinical context determines management—symptomatic patients need urgent ACS workup with angiography, while asymptomatic patients need Brugada evaluation and risk stratification for sudden death.